| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — |
| Net Income | $0.0B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $3.03 | $3.73 | $3.35 | $3.26 | $2.51 | $1.74 |
| EPS (Diluted) | $2.92 | $3.62 | $3.23 | $3.17 | $2.47 | $1.71 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Total Assets | $4.2B | $4.2B | $3.9B | $3.9B | $3.6B | $3.2B |
| Current Assets | — | — | — | — | — | — |
| Cash & Equivalents | $0.4B | $0.3B | $0.2B | $0.5B | $0.3B | $0.2B |
| Total Liabilities | $3.8B | $3.8B | $3.6B | $3.5B | $3.2B | $2.9B |
| Current Liabilities | — | — | — | — | — | — |
| Stockholders' Equity | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B | $0.3B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B |
| Investing Cash Flow | $-0.0B | $-0.1B | $-0.4B | $-0.2B | $-0.2B | $-0.2B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.0B | $0.2B | $0.0B | $0.3B | $0.3B | $0.1B |